EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis

Franziska Axhausen, Anne Mrochen, Pia Winter, Romy Baumgart, Pauline Mühlenbrock iD, Anna Mück, Stephanie Wolff, Sven G Meuth, Kathrin Möllenhoff, Steffen Pfeuffer iD

Multiple Sclerosis Journal · 2025

DOI: 10.1177/13524585251361330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multiple Sclerosis Journal, 2025. Verfasst von Franziska Axhausen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Giessen and Marburg, Justus-Liebig-University Giessen, Giessen, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Multiple Sclerosis, Immunologic Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ocrelizumab (OCR) and ofatumumab (OFA)are approved and their differences in dosing route and interval allow personalized treatment. However, there are no data on whether lateral switches between both substances affect treatment effectiveness or safety.

Methods

We screened our local cohort of MS patients, who began OCR since 09/2020 or OFA since 09/2021. Patients with a lateral switch were matched to controls who continuously received initial B-cell depleting therapy (BCT). We compared disease courses including effectiveness outcomes as well as peripheral CD19+ B-cell counts and serum IgG levels.

Results

From 09/2020 to 03/2024, 713 patients were subjected to BCT (OCR: 396; OFA: 317 [as in Fig.1]). The matched OCR cohort included 38 switchers and 149 controls. The OFA cohort consisted of 24 switchers and 83 controls. Effectiveness outcomes were comparable among switchers and controls. B cell depletion appeared slightly pronounced following a switch. Serum IgG levels declined faster among switchers compared to controls (OCR: 9.7 vs 9.0 g/L; p = 0.007 ; manifest hypogammaglobulinemia (HGG) in 13.2% vs 6.0%; OFA: 9.7 vs 8.4 g/L; p = 0.016 ; manifest HGG in 8.3% vs 2.4%).

Conclusions

Lateral switching between BCT does not abate effectiveness in this matched real-world cohort. Our observation of increased loss of IgG warrants further validation, but may indicate niche-specific immunological effects of OFA and OCR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedMultiple SclerosisImmunologic FactorsHumansFemaleMaleAdultMiddle AgedAntigens, CD20B-LymphocytesImmunoglobulin GTreatment Outcome

Stichwörter der Autor:innen

Multiple sclerosishypogammaglobulinemialateral switchocrelizumabofatumumab

Substanzen

Antibodies, Monoclonal, HumanizedocrelizumabofatumumabImmunologic FactorsAntigens, CD20Immunoglobulin G

Autor:innen und Institutionen

  • Department of Neurology, University Hospital Giessen and Marburg, Justus-Liebig-University Giessen, Giessen, Germany.
  • Department of Neurology, University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Dusseldorf, Germany.
  • Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Cologne, Germany.

ORCID-Profile: Pauline Mühlenbrock, Steffen Pfeuffer

Zitieren

APA

Axhausen, F., Mrochen, A., Winter, P., Baumgart, R., Mühlenbrock, P., Mück, A., Wolff, S., Meuth, S. G., Möllenhoff, K., & Pfeuffer, S. (2025). Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585251361330

Vancouver

Axhausen F, Mrochen A, Winter P, Baumgart R, Mühlenbrock P, Mück A, et al. Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis. Multiple Sclerosis Journal. 2025. doi:10.1177/13524585251361330

BibTeX
@article{Axhausen2025,
  author = {Axhausen, Franziska and Mrochen, Anne and Winter, Pia and Baumgart, Romy and Mühlenbrock, Pauline and Mück, Anna and Wolff, Stephanie and Meuth, Sven G and Möllenhoff, Kathrin and Pfeuffer, Steffen},
  title = {Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis},
  journal = {Multiple Sclerosis Journal},
  year = {2025},
  doi = {10.1177/13524585251361330}
}
Kostenlos starten →